NEW YORK (Reuters Health) – Beta-blockers can improve survival and reduce exacerbations of chronic obstructive pulmonary disease (COPD) – even in patients with cardiovascular disease, a new study…
NEW YORK (Reuters Health) – Superficial, or “nuisance,” bleeding troubled more than a quarter of patients on dual-antiplatelet therapy following the implantation of drug-eluting stents, according to new…
NEW YORK (Reuters Health) – Giving a single antenatal course of intramuscular corticosteroids after 34 weeks of gestation significantly enhances fetal lung maturity in pregnancies with documented fetal…
NEW YORK (Reuters Health) – A woman who has had one breech presentation is at increased risk for the same in later pregnancies, researchers in Australia report. They…
NEW YORK (Reuters Health) – Lipid-lowering therapy reduces cardiovascular events and all-cause mortality in patients with atrial fibrillation, according to a post hoc analysis of the AFFIRM study.…
NEW YORK (Reuters Health) – Patients with a textbook case of “typical” angina are no more likely than patients with atypical or nonanginal chest pain to have inducible…
NEW YORK (Reuters Health) – Does vaccination against pneumococcal pneumonia reduce the risk of acute myocardial infarction (MI) or stroke? Apparently not, according to a study of more…
NEW YORK (Reuters Health) – Adding inhaled treprostinil (Tyvaso) to oral bosentan for pulmonary arterial hypertension (PAH) improves exercise capacity and quality of life, according to a report…
NEW YORK (Reuters Health) – The angiotensin II receptor blocker olmesartan medoxomil (Benicar) significantly reduces blood pressure in children with primary or secondary hypertension, according to an international…
NEW YORK (Reuters Health) – In nondiabetics, high glucose levels signal an increased risk for contrast-induced acute kidney injury during coronary angiography, new research suggests. “Although diabetes is…